FAM225B Is a Prognostic lncRNA for Patients with Recurrent Glioblastoma.
Junsheng LiQian ZhangPeicong GeChao-Fan ZengFa LinWen WangJi-Zong ZhaoPublished in: Disease markers (2020)
FAM225B is expected to be as a new prognostic biomarker for the identification of rGBM patients with poor outcome. And our study provided a potential therapeutic target for rGBMs.
Keyphrases